Who owns Verona Pharma Plc ads?
- Ticker: VRNA
- CUSIP Number: 925050106
Tip: Access positions for across all investors
Analyze quarterly positions in Verona Pharma Plc ads with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Verona Pharma Plc ads stock
Who bought or sold Verona Pharma Plc ads this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
RA Capital Management | 6.3M | $126M | 0% | Dec 2023 |
|
NEA Management Company | 5.1M | $111M | 0% | Dec 2023 |
|
Perceptive Advisors | 3.9M | $77M | -4% | Dec 2023 |
|
Wellington Management Company | 3.8M | $75M | -15% | Dec 2023 |
|
OrbiMed Advisors | 3.8M | $75M | 0% | Dec 2023 |
|
Vivo Capital | 3.6M | $58M | -15% | Mar 2024 |
|
Frazier Life Sciences Management | 3.0M | $60M | 0% | Dec 2023 |
|
Federated Investors | 2.5M | $50M | 0% | Dec 2023 |
|
Carlyle | 2.5M | $49M | 0% | Dec 2023 |
|
Octagon Capital Advisors | 2.4M | $47M | 0% | Dec 2023 |
|
Henderson Group | 1.8M | $36M | 10% | Dec 2023 |
|
Maverick Capital | 1.7M | $33M | 100% | Dec 2023 |
|
Jennison Associates | 1.6M | $32M | 10% | Dec 2023 |
|
Eventide Asset Management | 1.4M | $27M | 62% | Dec 2023 |
|
First Turn Management | 1.2M | $24M | 100% | Dec 2023 |
|
Aisling Capital Management | 1.1M | $22M | 0% | Dec 2023 |
|
Bellevue Group | 840k | $17M | -2% | Dec 2023 |
|
Avidity Partners Management | 781k | $16M | -6% | Dec 2023 |
|
Laurion Capital Management | 584k | $12M | 100% | Dec 2023 |
|
Rice Hall James & Associates | 469k | $9.3M | 1712% | Dec 2023 |
|
Millennium Management | 383k | $7.6M | -59% | Dec 2023 |
|
Ikarian Capital | 368k | $257k | 15% | Dec 2023 |
|
Samsara BioCapital | 348k | $6.9M | 0% | Dec 2023 |
|
Moody Aldrich Partners | 321k | $6.4M | -9% | Dec 2023 |
|
Schonfeld Strategic Advisors | 302k | $6.0M | 59% | Dec 2023 |
|
Tri Locum Partners | 293k | $5.8M | -8% | Dec 2023 |
|
Walleye Trading Advisors | 257k | $5.1M | 2% | Dec 2023 |
|
Rosalind Advisors | 250k | $5.0M | 100% | Dec 2023 |
|
ClearBridge Advisors | 249k | $4.9M | 100% | Dec 2023 |
|
Knoll Capital Management | 200k | $4.0M | 0% | Dec 2023 |
|
Caligan Partners | 183k | $3.6M | 0% | Dec 2023 |
|
Caption Management | 172k | $3.4M | -5% | Dec 2023 |
|
Nicholas Investments Partners | 169k | $3.4M | -85% | Dec 2023 |
|
1492 Capital Management | 166k | $3.3M | 1% | Dec 2023 |
|
Kennedy Capital Management | 166k | $3.3M | 19% | Dec 2023 |
|
Artia Global Partners | 131k | $2.6M | 100% | Dec 2023 |
|
Superstring Capital Management | 124k | $2.5M | 100% | Dec 2023 |
|
Polar Securities | 97k | $1.9M | 0% | Dec 2023 |
|
Citadel Advisors | 87k | $1.7M | -61% | Dec 2023 |
|
Bank of America Corporation | 84k | $1.7M | -4% | Dec 2023 |
|
Legal & General Group | 81k | $1.6M | 19% | Dec 2023 |
|
Hennion & Walsh Asset Management | 67k | $1.1M | 71% | Mar 2024 |
|
Simplex Trading | 58k | $1.2M | 1416% | Dec 2023 |
|
ALPS Advisors | 54k | $1.1M | -8% | Dec 2023 |
|
Two Sigma Investments | 47k | $939k | 28% | Dec 2023 |
|
Us Bancorp | 42k | $837k | -23% | Dec 2023 |
|
Marshall Wace | 40k | $800k | 160% | Dec 2023 |
|
Goldman Sachs Group | 40k | $797k | 58% | Dec 2023 |
|
Bank of New York Mellon | 38k | $759k | 44% | Dec 2023 |
|
D.A. Davidson & Co. | 33k | $664k | 3% | Dec 2023 |
|
New York State Common Retirement Fund | 30k | $590k | 14% | Dec 2023 |
|
PFG Investments | 27k | $428k | 49% | Mar 2024 |
|
Walleye Trading | 21k | $419k | 8% | Dec 2023 |
|
DekaBank Deutsche Girozentrale | 20k | $415k | 0% | Dec 2023 |
|
Wells Fargo & Company | 18k | $349k | 23% | Dec 2023 |
|
Orion Portfolio Solutions | 17k | $341k | -8% | Dec 2023 |
|
Jane Street | 16k | $327k | -31% | Dec 2023 |
|
China Universal Asset Management | 15k | $296k | -73% | Dec 2023 |
|
Parkwood | 14k | $277k | -7% | Dec 2023 |
|
Jpmorgan Chase & Co | 13k | $254k | 0% | Dec 2023 |
|
Jump Financial | 11k | $226k | 100% | Dec 2023 |
|
HighTower Advisors | 11k | $209k | 100% | Dec 2023 |
|
Advisor Group Holdings | 3.1k | $62k | -25% | Dec 2023 |
|
Bnp Paribas Arbitrage, Snc | 2.0k | $40k | 125% | Dec 2023 |
|
UBS Group | 2.0k | $40k | -40% | Dec 2023 |
|
Cape Investment Advisory | 2.0k | $40k | 100% | Dec 2023 |
|
Royal Bank of Canada | 1.5k | $30k | 0% | Dec 2023 |
|
Citigroup | 1.2k | $24k | 45% | Dec 2023 |
|
Cutler | 1.2k | $18k | -15% | Mar 2024 |
|
Plante Moran Financial Advisors | 892.00 | $18k | 0% | Dec 2023 |
|
Zurcher Kantonalbank | 521.00 | $10k | -11% | Dec 2023 |
|
Main Street Group | 500.00 | $9.9k | 100% | Dec 2023 |
|
GAMMA Investing | 366.00 | $5.9k | 2053% | Mar 2024 |
|
EverSource Wealth Advisors | 295.00 | $5.9k | 100% | Dec 2023 |
|
Rhumbline Advisers | 277.00 | $5.5k | 40% | Dec 2023 |
|
Daiwa Securities Group | 244.00 | $5.0k | 0% | Dec 2023 |
|
Private Trust Co Na | 117.00 | $2.3k | 100% | Dec 2023 |
|
Global Retirement Partners | 50.00 | $871.000000 | 100% | Dec 2023 |
|
Bell Investment Advisors | 31.00 | $616.999200 | 0% | Dec 2023 |
|
Principal Securities | 26.00 | $516.999600 | 100% | Dec 2023 |
|
Larson Financial Group | 25.00 | $497.000000 | 0% | Dec 2023 |
|
Who sold out of Verona Pharma Plc ads?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Paradigm Biocapital Advisors | Sep 2023 | 926k | $15M |
Two Sigma Advisers | Sep 2023 | 48k | $779k |
Legato Capital Management | Dec 2023 | 24k | $484k |
Shay Capital | Sep 2023 | 14k | $220k |
Dynamic Technology Lab Private | Sep 2023 | 13k | $204k |
Cahill Wealth Management | Sep 2023 | 10k | $170k |
Balyasny Asset Management | Sep 2023 | 10k | $163k |
Pnc Financial Services | Sep 2023 | 212.00 | $3.5k |